Cat. No. 4044
Alternative Name: 619C89
Chemical Name: 2-(4-Methyl-1-piperazinyl)-5-(2,3,5
Biological ActivityBlocker of voltage-dependent sodium channels (NaV). Inhibits glutamate release; displays neuroprotective activity in rat models of cerebral ischemia. Also thought to block Ca2+ channels. Analog of lamotrigine (Cat. No. 1611).
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
Stefani et al (1998) On the inhibition of voltage activated calcium currents in rat cortical neurones by the neuroprotective agent 619C89. Br.J.Pharmacol. 125 1058. PMID: 9846645.
Graham et al (1994) Neuroprotective effects of a use-dependent blocker of voltage-dependent sodium channels, BW619C89, in rat middle cerebral artery occlusion. J.Pharmacol.Exp.Ther. 269 854. PMID: 7910213.
Leach et al (1993) BW619C89, a glutamate release inhibitor, protects against focal cerebral ischemic damage. Stroke 24 1063. PMID: 8100654.
If you know of a relevant reference for this product please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses Sipatrigine from Tocris? If so please let us know.
View Related Products by Product Action
Keywords: Sipatrigine, supplier, nav, voltage-dependent, sodium, Na+, channels, blockers, neuroprotective, Tocris Bioscience, Voltage-gated Sodium (NaV) Channel Blocker products